Advocacy in Action: Breakthrough T1D 2019 Government Day
After nearly 500 meetings with Members of Congress, Breakthrough T1D 2019 Government Day has officially come to a close. Over…
JDRF-Backed Start-Up Company to Accelerate Work Through Pfizer
AnTolRx, Inc., a private biotechnology company, has agreed to license its immune tolerance therapy for type 1 diabetes (T1D) to…
Eli Lilly Announces Lower-Cost Generic Insulin
Eli Lilly and Company announced it will begin selling a generic version of its most commonly prescribed insulin -- Humalog
Can a Snail Hold the Key to Better Blood Sugar Control?
Helena Safavi, Ph.D., of The University of Utah, decided to take an unusual and creative approach to ultra-rapid insulin development,…
Tracking Oxygen Levels Around Transplanted Cells Could Help Build Successful Beta Cell Replacement Therapies
Understanding change in oxygen levels over time in mice may help researchers develop better methods of replacing beta cells in…
In First-In-Human Tests, New Artificial Pancreas System Smartphone App Shows Reliable Glucose Control
Artificial pancreas (AP) systems “close the loop” between continuous glucose monitors and insulin pumps using algorithms to manage insulin. Learn…
Breakthrough T1D-Funded Researchers Reprogram Human Alpha Cells to Produce Insulin
Human cells, including pancreatic islet cells, are more adaptive than previously believed. Led by Dr. Pedro Herrera at the University…
Multiple Benefits of Screening For Beta Cell Autoimmunity in Children
Learn more about Breakthrough T1D’s prevention research and the benefits of early detection for type 1 diabetes (T1D).
Stem Cells to Beta Cells for Insulin Therapy: One Step Forward by Breakthrough T1D-Funded Researchers
Scientists have made a significant advancement in beta cell replacement research, potentially eliminating the need for insulin therapy for people…
ATTD Conference Brings Together Top Minds in Diabetes Research
Join diabetes researchers from around the world at the annual Advanced Technologies & Treatments for Diabetes (ATTD) conference. Breakthrough T1D-funded…
